Navigation Links
Chimerix Presents Update on CMX001 Development to the World Health Organization Advisory Committee on Variola Virus Research
Date:11/17/2010

ox release.  Chimerix has received significant funding from the National Institutes of Allergy and Infectious Disease to develop CMX001 for smallpox.

Chimerix's second clinical-stage antiviral compound, CMX157, has completed Phase 1 clinical studies.  CMX157 is in development as a potent nucleoside analogue against multi-drug resistant HIV infections.

Led by a world-class antiviral drug development team, Chimerix is also leveraging the company's extensive chemical library to pursue new treatments for hepatitis C virus, malaria and other global public health needs.  For additional information on Chimerix, please visit http://www.chimerix.com.


'/>"/>
SOURCE Chimerix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Chimerixs PIM Conjugate Technology Reduces Risk of Nephrotoxicity for CMX001 and CMX157
2. Chimerix Appoints Two New Vice Presidents to Clinical Management Team
3. Chimerix to Present at Upcoming Investor Conferences
4. Chimerix Initiates Phase 1 Study of CMX157
5. Chimerix Names George Painter, Ph.D., Chairman of the Board and Chief Scientific Officer; Appoints Kenneth I. Moch President and Chief Executive Officer
6. Chimerix Names Wendy Painter, M.D., M.P.H., as Chief Medical Officer
7. Chimerix, Inc. Appoints Kenneth I. Moch Chief Operating Officer
8. Chimerix Joins International Network of Organizations to Cure Malaria
9. Chimerix Completes Phase I Study and Initiates a Phase II Multi-dose Clinical Trial for CMX001
10. Aeterna Zentaris Presents Encouraging Preclinical Data on Two Novel Orally Active Anti-Cancer Compounds at Major Conference in Germany
11. Oramed Pharmaceuticals Presents Results of its Phase IIb Clinical Trial at the Diabetes Technology Meeting 2010 in Bethesda, MD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... 14, 2014 EquitiesIQ, a leading informational ... ALQA). Alliqua is an emerging biomedical company acquiring, developing, ... care market. , Free report download: http://equitiesiq.com/reports/alliqua/ ... seasoned management team and Board, which launched the company’s ...
(Date:1/14/2014)... iLab Solutions, the leader in core facility ... of Product Strategy. In this role, Michelle will work with ... guide in the development of iLab products. Her main goal ... benefit to the scientific community by offering the most advanced, ...
(Date:1/14/2014)... Global Record Systems, LLC, (GRS), ... solutions for patients, physicians, the biopharmaceutical industry, regulators, ... the signing of a three-year Research Collaboration Agreement ... (FDA). This initiative is designed to generate ...
(Date:1/14/2014)... Kerr Corporation, a leading manufacturer of innovative dental ... about dual arch impressions on its dental blog. ... blog entry serves up a list of tips to help ... by Dr. David Little as he crafts a porcelain crown ...
Breaking Biology Technology:EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3iLab Solutions Announces Michelle Detwiler as the New Director of Product Strategy 2Global Record Systems Announces Research Collaboration Agreement with FDA to Create a Novel “Big Data” Paradigm for Collection of Patient Safety and Outcomes Information 2
... Inc. (Nasdaq: SNMX ) will release its first ... the opening of the U.S. financial markets. The Company ... broadcast that will provide a corporate update and a review ... 11:00 a.m. Eastern Time (8:00 a.m. Pacific Time). To ...
... private insurers are placing unprecedented pressures on Life Sciences ... according to The 2009 Ernst & Young business risk ... to increase demands to demonstrate value in the years ... tax base, aging populations, and a mandate to provide ...
... April 23 HUNT Biosciences, the,commercial arm of ... the,appointment of former GE Healthcare director Per Foss ... healthcare companies with biomarker,discovery and validation services. These ... the past 25 years has gathered blood samples ...
Cached Biology Technology:SENOMYX, INC. FIRST QUARTER 2009 EARNINGS CONFERENCE CALL SCHEDULED FOR MAY 7, 2009 2Failing to Demonstrate Value of Innovation is Top Risk Facing Life Sciences Sector, According to Ernst & Young 2Failing to Demonstrate Value of Innovation is Top Risk Facing Life Sciences Sector, According to Ernst & Young 3Failing to Demonstrate Value of Innovation is Top Risk Facing Life Sciences Sector, According to Ernst & Young 4Former GE Healthcare Director, Per Foss Appointed CEO for HUNT Biosciences 2
(Date:7/9/2014)... from the oils produced by algae may offer a ... goal, optimization of cost effective strategies for large-scale algae ... Sapphire Energy has developed an innovative solution to the ... described in Industrial Biotechnology , a peer-reviewed journal ... available on the Industrial Biotechnology website ...
(Date:7/9/2014)... URBANA, Ill. With over 100 diseases that can ... the top of the most wanted list? University of ... reason that more research is needed on the fungus ... associated with cool, damp growing conditions but Macrophomina ... hot and dry drought conditions. , "As the climate ...
(Date:7/9/2014)... from China challenges the commonly held belief that birds ... to fly. The birdlike fossil is actually not a ... of a tiny tree-climbing animal that could glide, say ... Blanding, Utah, and Alan Feduccia of the University of ... of Ornithology . , The fossil of the ...
Breaking Biology News(10 mins):Controlling contamination in open algae ponds for biofuels 2Climate change provides good growing conditions for charcoal rot in soybeans 2Climate change provides good growing conditions for charcoal rot in soybeans 3Researchers declassify dinosaurs as being the great-great-grandparents of birds 2
... Research Vessel Polarstern had to prove its ice breaking ... series of long-term research measurements. After working in regions ... Wegener Institute for Polar and Marine Research in the ... August 10th. "This year, we had to cope ...
... the University Of Southern California School Of Dentistry have uncovered ... process that leads to palate formation. Cleft palate ... in one out of every 700 live births. Clefts are ... descent. While males are twice as likely to have a ...
... Ikaria Holdings, Inc., a fully,integrated critical care ... Drug Administration (FDA) has granted orphan drug designation,for ... of the incidence and,severity of delayed graft function ... Rosskamp, M.D., Executive Vice President of Research and,Development ...
Cached Biology News:Successful series of measurements in Arctic sea ice 2Successful series of measurements in Arctic sea ice 3Successful series of measurements in Arctic sea ice 4USC researchers identify alternate pathway that leads to palate development 2USC researchers identify alternate pathway that leads to palate development 3Ikaria(R) Receives FDA Orphan Drug Designation for Inhaled Carbon Monoxide for Delayed Graft Function in Solid Organ Transplants 2
... Simplify the process and you reduce ... built into the CEQ 8000. Developed using ... and leadership in capillary electrophoresis technology, the ... analysis system. This system automatically fills the ...
The external laser upgrade for the Molecular Imager FX adds a 635 nm external laser; the 555 nm long pass filter is replaced with a 605 nm band pass filter to distinguish Cy5 from 532 nm excitable dy...
... The APO-BRDU Kit is a 2-color ... total cellular DNA to detect apoptotic cells ... instructions and reagents required for measuring apoptosis ... cells for assessing reagent performance; washing, reaction ...
... The BioGenex VISION Sytem is a ... comes with proprietary digital imaging and ... digital image acquisition, analysis, archving/retrieval and ... a state-of-the-art digital imaging system that ...
Biology Products: